Levy Lends Insights Into the Current and Future Use of ADCs in NSCLC
Season 10 Episode 33 · May 30, 2024, 05:00 PM
Share
Subscribe
Dr Levy discusses the indication for trastuzumab deruxtecan in HER2+ NSCLC, other ADCs in development, and where the future of ADCs in NSCLC is headed.